Effect of activation or blockade of the phagocytic system on the antitumor activity of grifolan.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D005936:Glucans / Q000494:pharmacology; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D010586:Phagocytes / Q000187:drug effects*; D047071:beta-Glucans
D000970:Antineoplastic Agents; D005936:Glucans; D047071:beta-Glucans; C048444:grifolan